Form 8-K - Current report:
SEC Accession No. 0001193125-24-045464
Filing Date
2024-02-26
Accepted
2024-02-26 08:43:00
Documents
16
Period of Report
2024-02-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d794509d8k.htm   iXBRL 8-K 24274
2 EX-99.1 d794509dex991.htm EX-99.1 11880
6 GRAPHIC g794509g0223233412304.jpg GRAPHIC 4001
  Complete submission text file 0001193125-24-045464.txt   173357

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iron-20240226.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20240226_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20240226_pre.xml EX-101.PRE 11717
17 EXTRACTED XBRL INSTANCE DOCUMENT d794509d8k_htm.xml XML 3765
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 24673720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)